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Principles of using Cold
Atmospheric Plasma Stimulated
Media for Cancer Treatment
Dayun Yan1,*, Annie Talbot2,*, Niki Nourmohammadi3, Xiaoqian Cheng1, Jerome Canady4,
Jonathan Sherman5 & Michael Keidar1
To date, the significant anti-cancer capacity of cold atmospheric plasma (CAP) on dozens of cancer cell
lines has been demonstrated in vitro and in mice models. Conventionally, CAP was directly applied to
irradiate cancer cells or tumor tissue. Over past three years, the CAP irradiated media was also found to
kill cancer cells as effectively as the direct CAP treatment. As a novel strategy, using the CAP stimulated
(CAPs) media has become a promising anti-cancer tool. In this study, we demonstrated several
principles to optimize the anti-cancer capacity of the CAPs media on glioblastoma cells and breast
cancer cells. Specifically, using larger wells on a multi-well plate, smaller gaps between the plasma
source and the media, and smaller media volume enabled us to obtain a stronger anti-cancer CAPs
media composition without increasing the treatment time. Furthermore, cysteine was the main target
of effective reactive species in the CAPs media. Glioblastoma cells were more resistant to the CAPs
media than breast cancer cells. Glioblastoma cells consumed the effective reactive species faster than
breast cancer cells did. In contrast to nitric oxide, hydrogen peroxide was more likely to be the effective
reactive species.
During the past decade, cold atmospheric plasma (CAP), a near room temperature plasma mainly composed
of reactive oxygen species (ROS) and reactive nitrogen species (RNS)1, has been extensively investigated for its
promising application in anti-cancer therapy2,3. So far, CAP has shown a significant anti-cancer capacity over
a wide range of cancer cell lines, including carcinomas4,5, melanomas6,7, neuroectodermal malignancies8,9, and
hematopoietic malignancies10,11. In addition, the CAP also strongly resists tumor growth in mice12,13. Several general conclusions about the anti-cancer mechanism of CAP have been acknowledged. First, the rise of intracellular
ROS always occurs in cancer cells upon CAP treatment4,14, which causes a noticeable damage on the antioxidant
system15,16 and subsequently DNA double strands break (DSB) to a fatal degree1,17. Second, serious DNA damage
and other effect of CAP on cancer cells result in the cell cycle arrest18, apoptosis or necrosis with a dose-dependent
pattern19,20. Third, among diverse reactive species generated in CAP, H2O2 and NO are proposed to be key molecules
to kill cancer cells5,21. Fourth, untransformed normal cells always show stronger resistance to CAP than cancer
cells do12,22. Such killing preference on cancer cells is always accompanied with the distinct ROS levels and DSB
among cancer cells and normal cells23,24.
Conventionally, the CAP is directly used to irradiate cancer cells or tissue. Over past three years, the CAP
irradiated media was also found to kill cancer cells as effectively as the direct CAP treatment did8,25. In contrast to
the direct CAP treatment, the CAPs media has advantages. The CAPs media can be stored in the refrigerator and
maintain its anti-cancer capacity for at least 7 days26. Thus, the CAPs media might be a good fit for the condition
where a CAP device is not available. Moreover the CAPs media can be injected into tissues and effectively prevent
tumor growth27. These tissues may not be easily penetrated by the CAP jet, which only causes the cell death in the
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Figure 1. Schematic of the CAP device setup (a) and the general research strategy (b) to make the CAPs
media.

upper 3–5 cell layers of the CAP touched tissues28. To date, the anti-tumor capacity of the CAPs media has been
researched less than the direct CAP treatment. Therefore, basic principles to guide its application remain elusive.
In this study, four factors have been found to be capable of optimizing the anti-cancer capacity of the CAPs
media on glioblastoma cells (U87), breast cancer cells (MDA-MB-231 and MCF-7): the treatment time, the well
size, the gap between plasma source and liquid, and the volume of media,. Glioblastoma is the most lethal form
of brain cancer29. Due to its strong resistance to conventional therapy, the median survival time of patients is only
15 months29,30. CAP has shown promising anti-cancer capacity on glioblastoma cells in vitro8 and in vivo13. Breast
cancer is the most common women malignancy in United States31. Estrogen receptor-negative MDA-MB-231 cells
and estrogen receptor-positive MCF-7 cells are highly invasive and poorly invasive breast cancer cells, respectively32.
The vulnerability of these three cell lines to the CAPs media was compared. In addition, we investigated which
amino acids reacted most significantly with the effective reactive species by using the amino acids rich DMEM
and the cell probes we invented. It was determined that, compared with NO, H2O2 was more likely to be main
effective reactive species. Because the diffusion speed of H2O2 across the cellular membrane might directly affect
the intracellular ROS level, the consumption speeds of effective reactive species and H2O2 by cancer cells were studied. Ultimately, the anti-cancer effect of H2O2 rich DMEM was investigated to explore whether H2O2 was the only
effective reactive species. All detailed protocols were illustrated in Methods. This study built principles to guide the
application of the CAPs media and provided insight to understanding the anti-cancer capacity of the CAPs media.

Results

CAP device and general research strategy. The CAP device was a typical cold plasma jet generator using

helium as the carrying gas, which has been used in the study about the CAP effect on the cell surface integrins
expression33 and the response of glioblastoma cells upon the CAP treatment9,34. As shown in Fig. 1a, CAP was
generated between central electrode and ring electrode and flowed out of the quartz tube via the helium gas. A
flow meter controlled the helium flow at a rate of 4.7 L/min. The input voltage of DC power was 11.5 V. The output
voltage was 3.16 kV. The power supply was about 5 W.
The general research strategy is illustrated in Fig. 1b. A plasma jet vertically irradiated the media in the wells
in a 6-well plate. After treatment, the CAPs media was transferred to culture cancer cells, which had been seeded
in a 96-well plate. Before this step, the initial media which had been used to culture cancer cells overnight was
discarded. Then, cancer cells were cultured in the incubator under the standard conditions (a 37 °C, 5% (v/v) CO2
and humidified environment) for 72 hours. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide),
a colorimetric assay (Sigma-Aldrich) was harnessed to qualify the cell viability.

The reactive species accumulate in the CAPs media with a dose-dependent and liquid
surface-dependent pattern. Among dozens of species, NO in RNS and H2O2 in ROS are thought to play

key roles in killing cancer cells5,35. In addition, hydroxyl free radicals (.OH) in CAP are also proposed to kill cancer
cells36. To date, most of these conclusions are based on the research for the direct CAP treatment on cancer cells.
The understanding on the RNS and ROS accumulation in the CAPs media is far from clear. In this study, we first
studied the generation of NO and H2O2 in the CAPs complete media (90% DMEM +  10% FBS) via Griess Reagent
System (Promega) and Fluorimetric Hydrogen Peroxide Assay Kit (Sigma-Aldrich), respectively.
Next, we harnessed methylene blue (Fisher) to qualify the generation of .OH. In contrast to terephthalic acid,
which has also been used to qualify the .OH generation after plasma treatment36, methylene blue (MB) is a cheaper
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Figure 2. The dose-dependent ROS/RNS accumulation in the CAPs solution. (a) Relative RNS concentration
in 1 mL CAPs complete media. (b) Relative H2O2 concentration in 1 mL CAPs complete media. (c) Relative MB
concentration in 1 mL CAPs MB solution. (d) Relative MB concentration in 2 mL CAPs MB solution. Results
are presented as the mean ±  s.d. of three repeated experiments performed in triplicate. Student’s t-test was
performed, and the significance compared with the first bar is indicated as *p <  0.05, **p <  0.01, ***p <  0.005.
and more convenient probe. MB strongly reacts with .OH in the aqueous solution and changes its color from blue
into colorless, which can be detected by spectrophotometer at 664 nm37,38. The atmospheric plasma jet is a proven
MB decomposition tool39. We proved that MB was just sensitive to the species with a short half-life (Fig. S1).
Because MB is strongly absorbed by the proteins in the complete media, we investigated the generation of .OH in
the CAPs deionized water in this study.
Reactive species accumulate in the CAPs media with different patterns. To better illustrate these patterns, all
data in Fig. 2 have been normalized to be the relative values via dividing the data from experimental group by
the data from corresponding control group. RNS (Fig. 2a) and H2O2 (Fig. 2b) in the CAPs media both increase as
the treatment time increases. Because MB will be consumed after the reaction with .OH, corresponding relative
absorbance of the CAPs MB solution should be less than 1 (Fig. S1). However, as shown in Fig. 2c, noticeable .OH
generation was not observed even the treatment time was extended to 2 min. We performed the same experiment
in the MB solution with a larger volume (2 mL) and found that the generation of .OH was proportional to the
plasma treatment time again (Fig. 2d). This volume-dependent pattern may be due to the interaction between
plasma jet and solution. During the CAP treatment, the liquid below the plasma jet would be extruded, pushing
the solution to the perimeter of well (Fig. S2a). When the volume of liquid was just 1 mL, the plasma jet could not
touch liquid due to the exposure of the bottom of well. When the volume of liquid was up to 2 mL, the extrusion
of liquid would be weaker and enabled the plasma jet to touch the liquid layer. However, even when the plasma
jet does not touch the liquid, the reactive species are still able to dissolve into the liquid. Yonemori et al. observed
that when an atmospheric-pressure plasma jet touched a glass surface, it flowed radically over the glass surface and
formed a large area containing reactive species on the glass surface40. Thus, the reactive species in the plasma jet
should affect an area of liquid that is significantly larger than the diameter of the jet. The half-life of .OH is only a
few microseconds41, however, which eliminates the possibility that .OH diffuses over the liquid surface (Fig. S2a).
In contrast, H2O2 and NO with much longer half-life may enter the media by the diffusion over the whole surface
of liquid. We denote that H2O2/NO area and .OH area to represent the area mainly affected by H2O2/NO and .OH
on the liquid surface covered by plasma flow, respectively (Fig. S2a). Together, when the volume of media is relative
small, .OH will not be a main factor to directly affect the anti-tumor capacity of the CAPs media. .OH may react
with .OH to form H2O2 and affects the anti-tumor capacity indirectly.
If H2O2/NO area and .OH area do exist as we depicted in Fig. S2, it is reasonable to deduce that the surface
of media irradiated by the plasma may affect the accumulation of H2O2/NO but not .OH in the CAPs media. We
proved this deduction by measuring the production of H2O2/NO and .OH in the CAPs media and CAPs MB
solution in distinct multi-well plates, respectively. The well diameters on 48-well, 24-well, 12-well, and 6-well plate
were 10.2 mm, 15.4 mm, 21.4 mm, and 35.0 mm, respectively. We found that the H2O2/NO concentration in the
CAPs media varied significantly with the well size on the plate. The larger diameter of well, the more H2O2/NO
accumulated in the CAPs media (Fig. 3a,b). By contrast, the .OH generation in the CAPs MB solution doesn’t
significantly vary with the well size (Fig. 3c), even when the volume of MB solution is up to 2 mL (Fig. 3d). The .OH
generation in the CAPs MB solution from a 6-well plate is noticeably lower than that from other plates (Fig. 3c).
Scientific Reports | 5:18339 | DOI: 10.1038/srep18339
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Figure 3. The well size-dependent ROS/RNS accumulation in the CAPs solution. (a) Relative RNS
concentration in 1 mL of CAPs complete media. (b) Relative H2O2 concentration in 1 mL of CAPs complete
media. (c) Relative MB concentration in 1 mL of CAPs MB solution. (d) Relative MB concentration in 2 mL
CAPs of MB solution. Results are presented as the mean ±  s.d. of three repeated experiments performed
in triplicate. Student’s t-test was performed, and the significance compared with the first bar is indicated as
*p <  0.05, **p <  0.01, ***p <  0.005.

A schematic illustration in Fig. S2b depicts the underlying mechanism of the well size-effect on the reactive
species accumulation. A smaller well creates a smaller H2O2/NO area on the media surface. More H2O2/NO will
diffuse into the CAPs media when the well size becomes larger. Additionally, the thickness of media in the well
increases as the well size decreases. The calculated liquid thickness of 1 mL media in 48-well, 24-well, 12-well,
6-well plate are 12.2 mm, 5.4 mm, 2.8 mm, and 1.0 mm, respectively (Fig. S2b). Thus, the extrusion of media due
to the plasma jet pressure will be weakened as the diameter of well decreases. When the volume of MB solution
is just 1 mL, compared with the MB solution in 6-well plate, the MB solution in other multi-well plates is more
likely to contact the .OH in the CAP. Thus, more MB is consumed in the CAPs MB solution from 48-well, 24-well,
and 12-well plate than that from 6-well plate (Fig. 3c). Even when the volume of MB solution is 2 mL, .OH is only
able to affect a small area on the media directly touched by the CAP jet, so the .OH generation in the CAPs MB
solution changes little when the well size is noticeably altered. In short, the distinct half-life among H2O2/NO and
.OH underlies the different well size-effect of reactive species observed in this study.

The anti-tumor capacity of the CAPs media is dose-dependent and well size-dependent. We

further investigated the anti-tumor capacity of CAPs media on glioblastoma cells (U87), breast cancer cells
(MDA-MB-231 and MCF-7) with distinct cell confluences. It was found that the anti-tumor capacity of the CAPs
media increases as the treatment time (dose) increases and decreases as the cell seeding confluence decreases
(Fig. 4a–c). Thus, it is the dose of CAP treatment exerting on a unit cell, rather than the whole CAP treatment dose,
that determines the fate of cancer cells. In addition, MDA-MB-231 cells and MCF-7 cells are more vulnerable to
the CAPs media than U87 cells. The response of MDA-MB-231 cells and MCF-7 cells to the CAPs media is similar,
though MCF-7 cells are a little easier to be killed.
We further investigated effect of well size on the anti-tumor capacity of the CAPs media on the same three
cancer cell lines. We found that the anti-tumor capacity of the CAPs media decreased as the size of the wells
decreased (Fig. 4d–g). For U87 cells, the residual viability of cells cultured in the CAPs media from a 6-well plate
is about 1/3 of the viability of cells cultured in the CAPs media from a 48-well plate (Fig. 4d). In other words, at
least 2/3 of the anti-cancer ability of the CAPs media is wasted in the 48-well plate. A similar trend is also observed
on MDA-MB-231 cells (Fig. 4e). However, the well size-effect on MCF-7 cells only appears when the seeding
confluence is as high as 4 ×  104 cells/ml (Fig. 4g), which may be due to the fact that even the CAPs media from a
48-well plate is adequate to kill almost all MCF-7 cells with a seeding confluence as low as 2 ×  104 cells/ml (Fig. 4f).
Accordingly, the 96-well plate should waste more reactive species. By surveying all publications about the application of plasma jet on cancer treatment, it was determined that only 25% publications used 6-well plate or dish
with same size in their CAP treatment (Fig. S3). Thus, most investigations wasted significant amount of plasma,
gas and media over the past decade. The dose-dependent and the well size-dependent anti-cancer features of the
CAPs media is consisted with the dose-dependent and liquid surface-dependent reactive species accumulation
patterns in the CAPs media.
Scientific Reports | 5:18339 | DOI: 10.1038/srep18339
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Figure 4. The dose-dependent and well size-dependent anti-cancer capacity of the CAPs solution. The
relative viability of U87 cells (a), MDA-MB-231 cells (b), and MCF-7 cells (c) cultured in 1 mL of CAPs media
with different treatment time. (d) The relative viability of U87 cells (2 ×  104 cells/ml) (d), MDA-MB-231 cells
(2 ×  104 cells/ml) (e), MCF-7 cells (2 ×  104 cells/ml) (f), and MCF-7 cells (4 ×  104 cells/ml) (g) cultured in 1 mL
of CAPs media from different multi-well plates. The treatment time for (d–g) were 1 min. Results are presented
as the mean ±  s.d. of three repeated experiments performed in sextuplicate. Student’s t-test was performed, and
the significance compared with the first bar is indicated as *p <  0.05, **p <  0.01, ***p <  0.005.

Scientific Reports | 5:18339 | DOI: 10.1038/srep18339

5

www.nature.com/scientificreports/

Figure 5. The ROS/RNS accumulation in the CAPs media and the anti-cancer capacity of CAPs media
are gap-dependent. (a) Relative RNS concentration in 1 mL CAPs complete media. (b) Relative H2O2
concentration in 1 mL of CAPs complete media. (c) Relative viability of U87 cells (c), MDA-MB-231 cells (d),
and MCF-7 cells (e) cultured in 1 mL of CAPs complete media. The treatment time for all figures was 1 min.
Results are presented as the mean ±  s.d. of three repeated experiments performed in triplicate (a,b) or in
sextuplicate (c,d,e). Student’s t-test was performed, and the significance compared with the first bar is indicated
as *p <  0.05, **p <  0.01, ***p <  0.005.

The anti-tumor capacity of the CAPs media varies with the gap between plasma source and
media. For the media in the well with identical volume, when the well size decreases, the height of the media in

the well increases. Thus, the well size-dependent effect may be due to the altered size of the gap between the surface
of the media and the plasma source. We investigated the generation of NO and H2O2 in CAPs media by altering
the gap between the bottom of plate and the nozzle of quartz tube. We found that the NO and H2O2 in the CAPs
media shown a distinct response to a change in gap. As the gap increases from 2 cm to 4 cm, the concentration of
NO in the CAPs media shows a parabolic response. It reaches a peak at the gap of 3 cm and then decreases as the
gap is increased to 4 cm (Fig. 5a). The distribution of NO along the axial direction of the atmospheric pressure
plasma jet has been measured by laser induced fluorescence and showed similar trend as we observed42. In contrast, the concentration of H2O2 shows a stepwise change upon the gap increase. The concentration of H2O2 in
the CAPs media remains fairly constant over the gap of 2 cm to 3 cm. When the gap increased from 3 cm to 4 cm,
the concentration of H2O2 in the CAPs media decreased about 26% (Fig. 5b). Next, we investigated the viability
change of three cancer cell lines upon the gap change. As shown in Fig. 5c–e, the anti-tumor capacity of the CAPs
media dose not noticeably change until the gap increases to 3.5 cm or 4 cm. The gap-effect on the anti-cancer
capacity is consistent with the gap-effect on the generation of H2O2 but significantly differs from the gap-effect on
the generation of NO. It indicates that H2O2 rather than NO may dominate the death of cancer cells. Ultimately,
Fig. 5 proves that the well size-effect on the CAPs media is not due the gap-effect. Because the smaller gap only
tends to generate more reactive species, the actual well size-effect should be stronger than that shown in Fig. 4.
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Figure 6. The ROS/RNS accumulation in the CAPs media and the anti-cancer capacity of CAPs media
are volume-dependent. (a) Relative RNS concentration in the CAPs complete media. (b) Relative H2O2
concentration in the CAPs complete media. (c) Relative viability of U87 cells (c), MDA-MB-231 cells (d), and
MCF-7 cells (e) cultured in the CAPs complete media. The treatment time for all figures was 1 min. Results
are presented as the mean ±  s.d. of three repeated experiments performed in triplicate (a,b) or in sextuplicate
(c,d,e). Student’s t-test was performed, and the significance compared with the first bar is indicated as *p <  0.05,
**p <  0.01, ***p <  0.005.

The anti-cancer capacity is volume-dependent. As early as 2007, it was found that melanoma cells could

be protected in FE-DBD treatment by varying depth of cell growth media3. However, the mechanism underlying
the protecting role of media remains obscure. As we have demonstrated, the strong anti-cancer capacity of the
CAPs media always accompanies a high concentration of species in the media. Because the increase of media depth
means the increase of media volume in the same container, the protecting role of media may just due to the dilution
of reactive species in the media. We investigated the volume-effect on the anti-cancer capacity of the CAPs media.
It was found that both the concentrations of H2O2 (Fig. 6a) and NO (Fig. 6b) decreased as the volume of media
increased. Furthermore, the killing capacities of the CAPs media on three cancer cell lines significantly decreased
as the volume of media increased (Fig. 6c–e). In short, the protecting role of media is due to the dilution-effect of
the reactive species. According to this principle, the optimized anti-cancer capacity of CAP treatment, direct or
indirect, can be achieved when cells are surrounded by a few media.

Cysteine and tryptophan are the main targets of effective species in the CAPs media.

Here,
we denote effective species to represent the effective reactive species which kill cancer cells. Understanding the
chemical essence of the reaction between the effective species and the intracellular molecules is a prerequisite
to understanding the mechanism underlying the anti-cancer capacity of CAP treatment. However, to study the
intracellular reaction between RNS/ROS with the thousands of intracellular molecules directly is too challenging
to be performed. In this study, we focused on revealing which amino acids significantly reacted with the effective
species. The interaction between CAP and the amino acid solution have been studied via mass spectra. It was found
that the sulfur-containing and aromatic amino acids in the aqueous solution were preferentially consumed in the
CAP treatment43. Methionine, cysteine, tryptophan, phenylalanine, and tyrosine were the five most consumed
Scientific Reports | 5:18339 | DOI: 10.1038/srep18339
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reactive amino acids upon the CAP treatment43. However, some amino acids may be consumed by the species
which do not kill cancer cells. The revealed reaction types between amino acids and plasma have not answered the
question of which amino acids tend to react with the effective species.
We harnessed a novel strategy to reveal the reaction strength among effective species and specific amino
acids. We used cancer cells as a cell probe to investigate whether the effective species in the CAPs media would
be consumed by particular amino acids via comparing the anti-cancer capacity of a specific 2.4 mM CAPs amino
acids rich DMEM with the corresponding untreated amino acids rich DMEM. Each amino acids rich DMEM was
prepared by dissolving specific amino acids powers in DMEM.
Among 20 amino acids, cysteine and tryptophan showed the strongest reactivity towards the effective species
in CAPs media. In contrast to DMEM, the cysteine rich DMEM consumes most effective species and almost completely eliminates the anti-tumor capacity of the CAPs DMEM on U87 cells (Fig. 7a), MDA-MB-231 cells (Fig. 7b),
and MCF-7 cells (Fig. 7c). Tryptophan has a similar but weaker capacity to consume effective species. A control
group was also analyzed for each amino acid tested, because if a specific amino acid rich DMEM is toxic to cancer
cells, the corresponding control group has a very low cell viability, which makes the relative cell viability in Fig. 7
appears very large. As a result, we may get a delusion that a toxic amino acid consumes most effective species.
In this study, for U87 cells and MCF-7 cells, tryptophan shows a strong resistance to growth of cancer cells (Fig.
S4a,c). The mechanism underlying this toxicity is unclear. We also found that the tryptophan-rich DMEM did not
resist the growth of MDA-MB-231 cells (Fig. S4b). Thus, the weak anti-tumor capacity of the CAPs tryptophan
rich DMEM on MDA-MB-231 cells conclusively demonstrates that tryptophan is the second most sensitive amino
acid to the effective species. In addition, the CAP treated DMEM tends to cause the most cell death among most
CAPs amino acid rich DMEM. Thus, the effective species in CAP reacts with wide range of amino acids. Other
than cysteine and tryptophan, arginine, lysine, asparagine, and glutamine also react significantly with the effective
species in the CAPs media. Thus, they should also be the hot targets of effective species.
Furthermore, we studied the generation of H2O2 and NO in the CAPs amino acid rich DMEM, which will reveal
the species reacting strongly with specific amino acids. In contrast to NO, H2O2 is more likely to be the effective
species, because no significant difference of NO generation exists between different CAPs amino acids rich DMEM
(Fig. 8a), while H2O2 in the CAP simulated amino acid DMEM varied specifically with the amino acids in DMEM.
Most of the hot targeted amino acids of effective species are also capable of consuming H2O2 significantly in the
CAPs DMEM (Fig. 8b). There are 15 amino acids that consume the H2O2 generated in the CAPs DMEM, which
is consistent with the conclusion made above that many amino acids react with the effective species in the CAP
treated DMEM. Among them, cysteine rich DMEM consumes almost all H2O2. Despite tryptophan is the second
most sensitive amino acids to H2O2, it just consumes about 23% of H2O2 as cysteine does.

Cancer cells consume the reactive species with a cell line-dependent pattern. Due to the obscure

essence of the effective species in the CAP, the consumption speed of the effective species by cancer cells has not
been reported. Briefly, in this study, we harnessed one cancer cell line (MDA-MB-231) as the cell probe to investigate how much the effective species were left in the CAPs media which had been used to culture three cancer cell
lines for a period of time (Fig. S5). We denoted such CAPs media and such time as residual media and consumption
time, respectively. The viability of cell probes (MDA-MB-231) was inversely proportional to the concentration
of residual effective species in the residual media. The detailed protocols were illustrated in Fig. S5. It has been
found that the effective species in the residual media are gradually consumed by all three cell lines, which causes
the viability of cell probe (MDA-MB-231 cells) cultured in residual media to increase as the consumption time
increases (Fig. 9a). In addition, the cell probe (MDA-MB-231 cells) cultured in the residual media which has been
used to culture U87 cells obtains higher cell viability than the cell probe cultured in the residual media which has
been used to culture MDA-MB-231 cells and MCF-7 cells (Fig. 9a). In other words, U87 cells consume the effective
species significantly faster than MDA-MB-231 cells and MCF-7 cells. For U87 cells, the residual CAPs media almost
completely lose its anti-cancer capacity 3 hours after treatment. In contrast, for MDA-MB-231 cells and MCF-7
cells, the CAPs media still maintain significant anti-cancer capacity 3 hours after treatment. MDA-MB-231 cells
and MCF-7 cells consumes the effective species similarly.
Because H2O2 was regarded as the main effective species in the CAPs media, we further investigated the decay
speed of H2O2 in the residual media by measuring the evolution of H2O2 in the CAPs media which had been used
to culture three cell lines. We found that the H2O2 in the residual media which had been used to culture U87 cells
decayed noticeably faster than the cells in the residual media which had been used to culture MDA-MB-231 cells
and MCF-7 cells (Fig. 9b). Thus, U87 cells are capable of consuming H2O2 faster than MDA-MB-231 cells and
MCF-7 cells.

H2O2 alone does not equal to the CAPs media. To investigate whether H2O2 was the sole factor in causing

the death of cancer cells, we studied the response of three cancer cell lines to the H2O2 rich media. The H2O2 rich
media was prepared by adding 30 wt % H2O2 solution (Sigma-Aldrich) into the complete media. Because H2O2
reacted with proteins in the complete media, the real concentration measured by Fluorimetric Hydrogen Peroxide
Assay Kit (Sigma-Aldrich) was much less than the nominal concentration based on calculation in preparation. As
shown in Fig. 10, the growth of three cell lines presents a similar concentration (dose)-dependent response to the
H2O2 rich media. The growth of three cell lines will not be drastically suppressed until the concentration of H2O2
is adequately large. It is not surprising, because high dose of H2O2 produces cell death44. However, the responses
of three cancer cells to H2O2 are quite different. Generally, U87 cells and MCF-7 cells show stronger resistance
to H2O2 than MDA-MB-231 cells. U87 cells and MCF-7 cells share a similar response to H2O2 except when the
nominal concentration is between 20 to 50 μ M. Clearly, the selective anti-tumor capacity of H2O2 on three cells
lines are distinct from that of the CAPs media on these cell lines (Fig. 4 and Fig. S6). U87 cells are more resistant to
the CAPs media than both MCF-7 cells and MDA-MB-231 cells. MDA-MB-231 cells are a slightly more resistant
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Figure 7. Cysteine and tryptophan are the most reactive amino acids towards the effective species in the
CAPs DMEM. Relative cell viability of U87 cells (a), MDA-MB-231 cells (b), and MCF-7 cells (c) cultured in
the CAPs amino acids rich DMEM (2.4 mM). The treatment time for all figures was 1 min. Results are presented
as the mean ±  s.d. of three repeated experiments performed in sextuplicate. Student’s t-test was performed, and
the significance compared with the bar of DMEM is indicated as *p <  0.05, **p <  0.01, ***p <  0.005. Red arrows
mark the amino acids which are significantly weaken the anti-cancer capacity of CAPs media for three cell lines.

to the CAPs media than MCF-7 cells. These differences demonstrate that H2O2 is not the only reactive specie to
cause the death of cancer cells. Some other species also play necessary role. Cysteine may react with not only H2O2
but also other effective species in the CAPs media.
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Figure 8. In contrast with NO, H2O2 is more reactive with amino acids. The concentration of RNS (a) and
H2O2 (b) in the CAPs amino acids rich DMEM (2.4 mM). (a) is presented as the mean ±  s.d. of three repeated
experiments performed in sextuplicate. (b) is presented as the mean ±  s.d. of two repeated experiments
performed in sextuplicate. Student’s t-test was performed, and the significance compared with the bar of DMEM
is indicated as *p <  0.05, **p <  0.01, ***p <  0.005. Red arrows mark the amino acids which are significantly
weaken the anti-cancer capacity of CAPs media for three cell lines.

Discussion

So far, the anti-tumor capacity of CAP treatment has been regulated by controlling the treatment time3, the gas
sources composition34,45, the gas flow rate34, and the supply voltages46. Gold nanoparticles6,9 and some small molecules such as osmolytes47 and 2-deoxy-d-glucose48 were also used to obtain a synergistic anti-cancer effect. In this
study, we demonstrated several methods to obtain stronger anti-cancer capacity of the CAPs media. Specifically,
the CAP treatment should be performed in a container with a large diameter. In addition, the gap between the
plasma source and the media should be adequately small. To obtain high reactive species concentration, the volume
of media should be relative small. Because these principles are fit for all cell lines involved in this study, they may
be universal for other cancer cells.
Because 20 amino acids are the building blocks of all proteins, cysteine, the most reactive amino acid determined
by cell probes, should also be the main targeted amino acid residue on the intracellular proteins or other small
molecules. Intracellular ROS levels and redox balance are tightly regulated by multiple antioxidant defense systems,
including small antioxidant molecules such as glutathione, NAD(P)H and ROS-scavenging enzymes such as catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase, thioredoxin, thioredoxin reductase, and
peroxiredoxin49. Redox status of thiol group on the cysteine residue directly determines the function of glutathione
peroxidase50, thioredoxin51, thioredoxin reductase52,53, and peroxiredoxin54. When thiold group on the cysteine
residue was oxidized, corresponding normal function of some anti-oxidant enzymes or small molecules will be
completely lost. Here, we take glutathione, the most abundant small molecular thiol inside mammalian cells55, as
an example. Reduced form of glutathione (GH) is a tripeptide with a cysteine residue in the middle. When GH is
oxidized, the cysteine residue will form a disulfide bond with the cysteine residue on another GH. Such product is
denoted as GSSG. GSSG loses the ability to be a anti-oxidant molecule55. Actually, the weakend antioxidant system
has been observed in the plasma treated cancer cells15,56. The weakened intracellular anti-oxidant system facilitates
the attack of extracellular ROS on cells, and ultimately results in serious ROS rise4,24 and oxidative damage including
DSB1,17 and carbonyl content formation15.
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Figure 9. The consumption speed of effective species in the CAPs media by cancer cells. (a) Cell probe
(MDA-MB-231 cells) was used to discriminate how fast the effective species in the CAPs media consumed
by three cancer cell lines. The cell probe viability in this figure represents the ratio of the viability of cell
probe (MDA-MB-231 cells) cultured in the residual CAPs media which has been used to culture U87 cells,
MDA-MB-231 cells, and MCF-7 cells for a period of time to the viability of cell probe (MDA-MB-231 cells)
cultured in the complete media without CAP treatment. (b) The H2O2 concentration in the residual CAPs
media which has been used to culture U87 cell, MDA-MB-231 cells, and MCF-7 cells for a period of time.
Results are presented as the mean ±  s.d. of three repeated experiments performed in sextuplicate (a) or triplicate
(b). Student’s t-test was performed, and the significance compared with the first bar (consumption time of 0 hr)
is indicated as *p <  0.05, **p <  0.01, ***p <  0.005.

Like other ROS, the toxicity of H2O2 to cells are dose-dependent. Only the high dose of H2O2 can produce cell
death44. The toxicity of H2O2 is exaggerated by the Fenton reaction between H2O2 and Fe2+ in cells, which generates high reactive .OH and causes damage to DNA and other important intracellular molecules57. H2O2 has been
proposed as a key species to cause the death of cancer cells after CAP treatment 21,26,35. However, the biochemical
analysis on the cancer cells following the treatment of CAP and H2O2 demonstrates the distinct phosphorylation
levels on c-Jun amino-terminal kinases and p38 protein kinases35. Our study revealed that the H2O2 rich media
could not generate the same selective killing on cancer cell lines as well as the CAPs media did. Thus, the CAP
treatment can not equate to the H2O2 treatment.
In contrast to H2O2, NO was not likely to be the main effective species. However, the real role of NO in killing
cancer cells has not been deeply explored in this study. Theoritically, NO may result in the general observed ROS
increase and the death of cancer cells after CAP treatment. NO is able to increase intracellular ROS levels by
blocking the electron transport chain in mitochondria58 and inactivating the glutathione peroxidase59. NO reacts
with superoxide to generate peroxynitrite, which will not only attack DNA but also weaken the antioxidant system
via the inactivation of manganese-superoxide dismutase60,61, glutathione peroxidase62, glutathione reductase63,64,
catalase65, and peroxiredoxin66. In addition, other effective species which have not been studied may also contribute
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Figure 10. The anti-cancer capacity of the H2O2 rich media on U87 cells, MDA-MB-231 cells, and MCF-7
cells. The real concentration measured by Fluorimetric Hydrogen Peroxide Assay Kit (Sigma-Aldrich) is shown
in the parenthesis following the nominal concentration based on the calculation in preparation. The equivalent
CAP treatment time (eqT) is shown in the bottom of figure. eqT was calculated based on the formula that
eqT =  (measured H2O2 concentration in the H2O2 rich media, mC) ×  (conversion coefficient, cC). Here, cC
is 0.03. For example, eqT of 1.211 =  mC of 40.35 times cC of 0.03. To obtain cC, we first measured the H2O2
concentration in the media which has been treated by CAP for 0.5, 1, 1.5, and 2 min. Then, the linear fitting
between the measured H2O2 concentration and the treatment time helped us to get cC. Results are presented as
the mean ±  s.d. of three repeated experiments performed in sextuplicate. Student’s t-test was performed, and the
significance compared with the first bar (nominal concentration of 1 μ M) is indicated as *p <  0.05, **p <  0.01,
***p <  0.005.

to the death of cancer cells. Thus, the number of species that codetermine the anti-cancer capacity of CAPs media
is still unknown.
Recently, two trends regarding the response of cancer cells to the CAP treatment have been found. First, the
anti-tumor capacity of CAP on cancer cells is proportional to the growth speed of cancer cell lines67. Second, the
cancer cells carrying mutated p53 genes are more vulnerable to the CAP treatment than the cancer cells carrying wild p53 genes68. The second trend might explain the first trend to some extent. Cancer cell lines carrying
the mutated p53 gene tend to obtain malignant69 or metastasis phenotypes70,71 and overcome growth arrest and
senescence72. The cancer cells in metastasis stage own prosperous metabolism and high ROS level73,74. Thus, the
fast growing cancer cells without a normal, functional p53 gene are more vulnerable to the CAP treatment. In this
study, however, we found a new trend that the cancer cells that could absorb or eliminate the effective species in
the surrounding environment faster would be more resistant to the CAPs media. Despite the fact that the intrinsic
relationship between these trends was obscure, we demonstrated that the absorption capacity on the effective
species and H2O2 by cancer cells significantly varied with the cell lines.
The absorption of reactive species, mainly H2O2 in this study, directly relates to the diffusion speed of reactive
species across the cellular membrane. H2O2 has been regarded as a molecule that is able to freely cross the phospholipid membrane75. Recent investigations revealed that diffusion of H2O2 across phospholipid membrane was
limited by the membrane composition75. Due to the highly similarity among H2O2 and water, aquaporins (AQPs), a
membrane protein family facilitating the transport of water across the cellular membrane, also plays an important
role in facilitating the passive diffusion of H2O276. Not all AQPs are able to transport H2O2. So far, only the transport
of H2O2 by AQP1 and AQP8 has been investigated. AQP1 with a relative smaller pore diameter in the selectivity
filter region (2.7 Å) cannot transport H2O275,77. By contrast, due to the larger pore diameter (3.2 Å)56, AQP8 is able to
transport H2O2 across the cellular membrane78. AQPs are expressed to varying degrees in different types of human
tumors. For example, AQP1, 4, and 5 highly express in breast cancer cell lines79,80. AQP1, 4, 8, and 9 highly express
in glioblastoma cell lines81–83. The distinct expression pattern of AQP8 in glioblastoma cells and breast cancer cells
can explain why H2O2 is consumed faster by U87 cells than MCF-7 and MDA-MB-231. Nonetheless, if H2O2 is
the main effective species to kill cancer cells, the intracellular H2O2 level should be at least codetermined by the
diffusion speed of H2O2 across the cell membrane and the intracellular H2O2 scavenging system75. Thus, we may
not be able to predict the vulnerability of cancer cells to the CAPs media only based on the distinct consumption
speeds of cancer cells. More research focusing the intracellular H2O2 scavenging capacity in distinct cancer cells
should be carried out in the future.

Conclusions

In summary, we demonstrated several principles to optimize the anti-tumor capacity of the CAPs media on glioblastoma cells and breast cancer cells. Specifically, a larger well, a closer gap between plasma source and media, and
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a smaller volume of media produce a stronger anti-cancer CAPs media. Breast cancer cells are more vulnerable to
the CAPs media than glioblastoma cells. In addition, compared with NO, H2O2 in the CAPs media is likely to be
the main effective species to kill cancer cells. The effective species in the CAPs media mainly react with cysteine,
which explains the rise of intracellular ROS in the CAP treated cancer cells. H2O2 and the CAPs media cause distinct
selective killing patterns in cancer cells, indicating that other reactive species may also affect the death of cancer
cells. Glioblastoma cells are able to consume effective species and H2O2 in the CAPs media significantly faster
than breast cancer cells, which may relate to the distinct expressions of cell membrane proteins on cancer cells.

Methods

Cell cultures. Human U87 cells were provided by Dr. Murad’s Lab at the George Washington University.
Human MDA-MB-231 cells and MCF-7 cells were provided by Dr. Zhang’s Lab at the George Washington
University. All cancer cell lines were cultured for 24 hours in a complete media composed of Dulbecco’s modified
Eagle’s medium (DMEM) (Life Technologies) supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlantic
Biologicals) and 1% (v/v) antibiotic (penicillin and streptomycin) solution (Life Technologies) under the standard
cell culture conditions (a humidified, 37 °C, 5% CO2 environment).
The dose-dependent NO, H2O2 accumulation in the CAPs media.

First, 1 mL of complete media
in a well on 6-well plate (Falcon) was treated by CAP for 0.5 min, 1 min, 1.5 min, and 2 min, respectively. The
gap between the bottom of the quartz tube and the bottom of plate was 3 cm. 50 μ L of CAPs complete media was
immediately transferred to a well on a black 96-well clear bottom plate (Falcon) in triplicate. As the control, 50 μ L
of untreated complete media was also transferred to a well on the same plate in triplicate. Next, according to the
standard protocols provided by Promega and Sigma-Aldrich, the NO and H2O2 concentration in the CAPs media
were measured, respectively. The absorbance at 540 nm and the fluorescence at 540/590 nm were read using a H1
microplate reader (Hybrid Technology).

The liquid surface-dependent NO, H2O2 accumulation in the CAPs media. First, 1 mL of complete

media in a well on 48-well, 24-well, 12-well, and 6-well plate (Falcon) were respectively treated by CAP for 1 min.
The gap between the outlet of the quartz tube and the bottom of plate was 3 cm. Then, 50 μ L of CAPs media from
different multi-well plates were immediately transferred to a well on the black 96-well clear bottom plate in triplicate. For the control, 50 μ L of untreated CAPs media was also transferred to a well on the same plate in triplicate.
Ultimately, we measured the NO/H2O2 concentration in the CAPs media.

The dose-dependent .OH accumulation in the MB solution. The MB solution was prepared by dissolv-

ing MB powder into deionized water. Then, 1 mL of 0.01 g/L MB solution in a well on 6-well plate was treated by
CAP for 0.5 min, 1 min, 1.5 min, and 2 min. The gap between the outlet of the quartz tube and the bottom of plate
was 3 cm. 100 μ L of CAPs MB solution was immediately transferred to a well on the black 96-well clear bottom
plate in triplicate. As the control, 100 μ L of untreated MB solution was also transferred to a well on the same plate
in triplicate. Ultimately, we measured the absorbance at 664 nm using a H1 microplate reader (Hybrid Technology).

The liquid surface-dependent .OH accumulation in the MB solution.

First, 1 mL of 0.01 g/L MB
solution in a well on 48-well, 24-well, 12-well, and 6-well plate were respectively treated by CAP for 1 min. The
gap between the outlet of quartz tube and the bottom of plate was 3 cm. Next, 100 μ L of CAPs MB solution was
transferred to a well on the black 96-well clear bottom plate in triplicate. 100 μ L of untreated MB solution was
also transferred to a well on the same plate in triplicate as the control. Ultimately, we measured the absorbance at
664 nm using a H1 microplate reader (Hybrid Technology).

The dose-dependent anti-cancer capacity of CAPs media. For each cell line, the protocol was iden-

tical. Here, we used U87 cells as an example. First, U87 cells were seeded in 96-well plate with three confluencies
(2 ×  104 cells/ml, 4 ×  104 cells/ml, and 8 ×  104 cells/ml) and cultured in an incubator for 24 hours under standard
conditions. Next, 1 mL of complete media in a well on 6-well plate was respectively treated by CAP for 0.5 min,
1 min, 1.5 min, and 2 min. The gap between the outlet of the quartz tube and the bottom of plate was 3 cm. 100 μ L
of CAPs media were immediately transferred to culture U87 cells in a well on the 96-well plate in sextuplicate.
100 μ L of untreated complete media was also transferred to culture U87 cells in a well on the same plate in sextuplicate as the control. Before this step, the media that was used to culture U87 cells overnight was discarded. After
that, U87 cells were cultured in the CAPs media for 72 hours. Ultimately, according to the standard method, the
viability of U87 cells were qualified by MTT test and were read by a H1 microplate reader (Hybrid Technology)
at the absorbance of 570 nm.

The well size-dependent anti-cancer capacity of CAPs media.

The protocols for three cell lines were
identical. Here, we used U87 cells as an example. First, U87 cells were seeded in a 96-well plate with a confluence of
2 ×  104 cells/ml and were cultured in an incubator for 24 hours under standard conditions. Next, 1 mL of complete
media in a well on 48-well, 24-well, 12-well, and 6-well plate were treated with CAP for 1 min. The gap between
the outlet of the quartz tube and the bottom of plate was 3 cm. Then, 100 μ L of CAPs media were immediately
transferred to culture U87 cells in a well on the 96-well plate in sextuplicate. As the control, 100 μ L of untreated
media was also transferred to culture U87 cells on the same plate in sextuplicate. Before this step, the media that
had been used to culture U87 cells overnight was discarded. After that, U87 cells were cultured in the CAPs media
for 72 hour. Ultimately, the cell viability was measured.

The gap-dependent NO/H2O2 accumulation in the CAPs media.

First, when the gap between the
outlet of the quartz tube and the bottom of the plate varied from 2 cm to 4 cm, 1 mL of complete media in a well on
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6-well plate was treated by CAP for 1 min. Then, 50 μ L of CAPs media was immediately transferred to a well on the
black 96-well clear bottom plate in triplicate. 50 μ L of untreated complete media was also transferred to a well on
the same plate in triplicate as the control. Ultimately, we measured the NO/H2O2 concentration in the CAPs media.

The gap-dependent .OH accumulation in the MB solution.

First, when the gap between the outlet
of the quartz tube and the bottom of the plate varied from 2 cm to 4 cm, 1 mL of 0.01 g/L MB solution in a well
on 6-well plate was treated by CAP for 1 min. Next, 100 μ L of CAPs MB solution was transferred to a well on the
black 96-well clear bottom plate in triplicate. 100 μ L of untreated 0.01 g/L MB solution was also transferred to
the same plate in triplicate for the control. We measured the absorbance at 664 nm using a H1 microplate reader
(Hybrid Technology).

The gap-dependent anti-cancer capacity of the CAPs media. The protocol for the three cell lines was

identical. Here, we used U87 cells as an example. First, U87 cells were seeded in 96-well plate with a confluence
of 2 ×  104 cells/ml and were cultured in incubator for 24 hours under standard conditions. Next, when the gap
between the outlet of the quartz tube and the bottom of plate varied from 2 cm to 4 cm, 1 mL of complete media in
a well on a 6-well plate was treated by CAP for 1 min. Then, 100 μ L of CAPs media were immediately transferred
to culture U87 cells in a well on 96-well plate in sextuplicate. 100 μ L of the untreated complete media was also
transferred to culture U87 cells in a well on 96-well plate in sextuplicate as the control. Before this step, the media
that was used to culture U87 cells overnight was discarded. U87 cells were then cultured in the CAPs media for
72 hours. Ultimately, the cell viability was measured.

The volume-dependent NO/H2O2 accumulation in the CAPs media.

First, 1 mL, 2 mL, 3 mL, and
4 mL of complete media in a well on 6-well plate were treated by CAP for 1 min. The gap between the outlet of the
quartz tube and the bottom of the plate was 3 cm. 50 μ L of CAPs complete media was immediately transferred to a
well on the black 96-well clear bottom plate in triplicate. 50 μ L of the untreated complete media was also transferred
to a well on the same plate in triplicate for the control. Ultimately, we measured the NO/H2O2 concentration in
the CAPs media.

The volume-dependent .OH accumulation in the MB solution. 1 mL, 2 mL, 3 mL, and 4 mL of 0.01 g/L

MB solution in a well on 6-well plate were treated by CAP for 1 min. The gap between the outlet of the quartz tube
and the bottom of the plate was 3 cm. 100 μ L of CAPs MB solution was transferred to a well on a black 96-well
clear bottom plate in triplicate. 100 μ L of untreated 0.01 g/L MB solution was also transferred to a well on the same
plate in triplicate for the control. Ultimately, we measured the absorbance at 664 nm using a H1 microplate reader.

The volume-dependent anti-cancer capacity of the CAPs media.

The protocols for three cell lines
were identical. Here, U87 cells were used as an example. First, U87 cells were seeded in 96-well plate with a confluence of 2 ×  104 cells/ml and were cultured in incubator for about 24 hours under standard conditions. Second,
1 mL, 2 mL, 3 mL, and 4 mL of complete media in a well on 6-well plate were treated by CAP for 1 min. The gap
between the outlet of the quartz tube and the bottom of the plate was 3 cm. Then, 100 μ L of CAPs complete media
was immediately transferred to culture U87 cells in a well on a 96-well plate in sextuplicate. 100 μ L of the untreated
complete media was also used to culture U87 cells in a well on same plate in sextuplicate for the control. Before
this step, the media which has been used to culture U87 cells overnight was discarded. After that, U87 cells were
cultured in the CAPs media for 72 hours. Ultimately, the cell viability was measured.

The anti-cancer capacity of CAPs amino acids rich DMEM. The protocol for three cell lines was iden-

tical. Here, U87 cells were used as an example. First, U87 cells were seeded in 96-well plate with a confluence of
2 ×  104 cells/ml and were cultured in an incubator for 24 hours under standard conditions. Second, we respectively prepared 2.4 mM specific amino acids rich DMEM by dissolving specific quantities of amino acids powers
(Sigma-Aldrich) in DMEM (1% ABS). Because some amino acid rich DMEM would be gradually oxidized by the
air during long storage even in the refrigerator, all prepared amino acid rich DMEM were discarded and renewed
every two weeks. Next, all 20 specific amino acid rich DMEM and normal DMEM were treated by CAP for 1 min
in a well on 6-well plate. The volume of solution in each well was 1 mL. The gap between the outlet of the quartz
tube and the bottom of the plate was 3 cm. 100 μ L of the CAPs amino acids rich DMEM and the CAPs normal
DMEM were transferred to culture U87 cells in a well on 96-well plate in sextuplicate. As the control, 100 μ L of
the untreated amino acid rich DMEM and normal DMEM were also used to culture U87 cells in a well on 96-well
plate in sextuplicate. Before this step, the media which has been used to culture U87 cells overnight was discarded.
After that, U87 cells were then cultured in the CAPs media for 72 hours. Ultimately, the cell viability was measured.

Measurement of NO/H2O2 in the CAPs amino acids rich DMEM.

First, all 20 specific amino acids
rich DMEM and normal DMEM were treated by CAP for 1 min in a well on 6-well plate. The volume of solution
in each well was 1 mL. The gap between the outlet of the quartz tube and the bottom of the plate was 3 cm. 50 μ L
of the CAPs amino acid rich DMEM and the CAPs normal DMEM were immediately transferred to a well on the
black 96-well clear bottom plate in triplicate. As the control, 50 μ L of the untreated amino acid rich DMEM and
normal DMEM were also transferred to a well on the same plate in triplicate. Ultimately, we measured the NO/
H2O2 concentration in the CAPs media.

Measurement of the consumption speed of H2O2 by cancer cells. The protocol for the three cell lines
is identical. Here, we used U87 cells as an example. First, U87 cells were seeded in 96-well plate with a confluence
of 1 ×  104 cells/ml and cultured in the incubator for 6 hours under the standard conditions. Then, 1 mL of complete
media was treated by CAP in 6-well plate for 1 min. After that, 120 μ L of the CAPs media was transferred to culture
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U87 cells on a 96-well plate. Since then, until the third hour, 50 μ L of the residual media that was used to culture
U87 cells was transferred to a well on the black 96-well clear bottom plate in triplicate. As the control, 100 μ L of
new complete media was also transferred to a well on the same plate in triplicate. Ultimately, we measured the
H2O2 concentration in the CAPs media.

The anti-cancer effect of H2O2 rich media. The protocol for the three cell lines was identical. Here, U87

cells were used as an example. First, U87 cells were seeded in 96-well plate with a confluence of 2 ×  104 cells/ml and
were cultured in an incubator for 24 hours under standard conditions. Then, 1 μ M, 5 μ M, 10 μ M, 20 μ M, 25 μ M,
50 μ M, and 100 μ M H2O2 rich media was prepared by mixing 30 wt % H2O2 solution (Sigma-Aldrich) with the
complete media. 100 μ L of these H2O2 rich media was transferred to culture U87 cells in a well on 96-well plate
in sextuplicate. 100 μ L of normal complete media was also used to culture U87 cells in a well of the same plate in
sextuplicate for the control. Before this step, the media which was used to culture U87 cells overnight was discarded.
After that, U87 cells were then cultured in the incubator for 72 hours. Ultimately, the cell viability was measured.
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